Sally Whiting Bain (@sbain09) / Twitter
Media Contacts - Sanofi
Sanofi makes $3.2B bet on mRNA by acquiring partner Translate Bio - Boston Business Journal
Uncharted: Healthcare Leadership Video Series | Bain & Company
Our Team | Sanofi Ventures
Code of Conduct | Sanofi
Sanofi adds first vaccine candidate against acne to its R&D pipeline with the take over of an Austrian privately held biotechnology firm | EuropaWire.eu | The European Union's press release distribution &
Media Contacts - Sanofi
Media Contacts - Sanofi
Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity | AZBio
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D) - Sanofi
New Paths to Value Creation in Pharma | Bain & Company
Media Update
Nicolas Dumas - Management Consultant | Bain & Company
Sanofi and Swansea collaborate on UK's first | EurekAlert!
Sanofi invests in health tech firm Novadiscovery, boosting trial simulation platform and COVID-19 work | Fierce Biotech
Sanofi revises fitusiran dosing to cut risk of thrombotic events in hemophilia phase 3 | Fierce Biotech
Provention Bio | Investor Relations - News
